HERPES SIMPLEX VIRUS VACCINE DEVELOPMENT: PIPELINES AND POSSIBILITIES

被引:0
|
作者
Johnston, Christine [1 ]
机构
[1] Univ Washington, Seattle, WA 98195 USA
关键词
D O I
10.1136/sextrans-2015-052270.41
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
S06.2
引用
收藏
页码:A13 / A13
页数:1
相关论文
共 50 条
  • [41] THE CONSTRUCTION OF LIVING VACCINE STRAINS - THE EXAMPLE OF HERPES-SIMPLEX VIRUS
    MEIGNIER, B
    BIOFUTUR, 1986, (51) : 39 - &
  • [42] Genetic engineering of a modified herpes simplex virus 1 vaccine vector
    Liu, XueQiao
    Broberg, Eeva
    Watanabe, Daisuke
    Dudek, Timothy
    DeLuca, Neal
    Knipe, David M.
    VACCINE, 2009, 27 (21) : 2760 - 2767
  • [43] Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development
    Lee, Amanda J.
    Ashkar, Ali A.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2012, 25 (01) : 92 - 99
  • [44] Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus
    Murphy, CG
    Lucas, WT
    Means, RE
    Czajak, S
    Hale, CL
    Lifson, JD
    Kaur, A
    Johnson, RP
    Knipe, DM
    Desrosiers, RC
    JOURNAL OF VIROLOGY, 2000, 74 (17) : 7745 - 7754
  • [45] EFFICACY OF HERPES VACCINE IN A RABBIT MODEL FOLLOWING INTRAOCULAR INOCULATION OF HERPES-SIMPLEX VIRUS
    NARANG, HK
    JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (06): : 973 - 979
  • [46] Herpes simplex virus infections [Herpes-simplex-virusinfektionen]
    Gross G.
    Der Hautarzt, 2004, 55 (9): : 818 - 830
  • [47] DNA vaccine expressing herpes simplex virus 1 glycoprotein C and D protects mice against herpes simplex keratitis
    Li-Li Dong
    Ru Tang
    Yu-Jia Zhai
    Tejsu Malla
    Kai Hu
    International Journal of Ophthalmology, 2017, 10 (11) : 1633 - 1639
  • [48] DNA vaccine expressing herpes simplex virus 1 glycoprotein C and D protects mice against herpes simplex keratitis
    Dong, Li-Li
    Tang, Ru
    Zhai, Yu-Jia
    Malla, Tejsu
    Hu, Kai
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (11) : 1633 - 1639
  • [49] Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains
    Chang, YJ
    Jiang, M
    Lubinski, JM
    King, RD
    Friedman, HM
    VACCINE, 2005, 23 (38) : 4658 - 4665
  • [50] RESTRICTION OF LATENT HERPES-VIRUS INFECTION IN RABBITS IMMUNIZED WITH SUBVIRAL HERPES-SIMPLEX VIRUS-VACCINE
    RAJCANI, J
    KUTINOVA, L
    VONKA, V
    ACTA VIROLOGICA, 1980, 24 (03) : 183 - 193